Veracyte, Inc. (VCYT)

Veracyte, Inc. (VCYT) is a healthcare company (diagnostics & research) based in the United States. The share price is $24.07, up 0.24% on the day, which values the company at $1.94B. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$24.07+0.24% today
Market value
$1.94B
P/E ratio
15.6×last 12 months
Forward P/E
15.5×
Funk Score
87/100
Against its own history
Well below its usual priceusual price $44.57
200-week average
$31.8324% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Veracyte, Inc. in more detail

VCYT trades at 15.6× its last twelve months' earnings, 15.5× next year's expected earnings, 3.3× sales. Measured against its own history, the price is 46% below what its usual multiples would imply ($44.57) — well below its usual price. It sits 24% below its 200-week average of $31.83.

Over the last five fiscal years Veracyte, Inc. has compounded revenue 34.5% a year. Its Funk Score is 87 out of 100 (financial strength 9.8, profitability 6.0, growth 10.0, value 9.1, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Share count keeps rising.

1 of the superinvestors tracked here hold VCYT, including Cathie Wood (0.8% of the portfolio).

Superinvestors holding VCYT

1 of the investors tracked here report a position in their latest 13F filing.

Veracyte, Inc. (VCYT): questions and answers

What is VCYT's P/E ratio?

Veracyte, Inc. trades at 15.6× its last twelve months' earnings and 15.5× next year's expected earnings.

What is Veracyte, Inc.'s market cap?

Veracyte, Inc. is valued at $1.94B at a share price of $24.07.

Is VCYT overvalued or undervalued?

Against its own history, VCYT is well below its usual price: the price is 46% below the $44.57 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is VCYT above its 200-week moving average?

No. VCYT is 24.4% below its 200-week average of $31.83. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Veracyte, Inc. growing?

Over the last five fiscal years Veracyte, Inc.'s revenue grew 34.5% a year; over ten years revenue grew 26.4% a year.

Does VCYT pay a dividend?

Veracyte, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Veracyte, Inc. (VCYT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VCYT

Underlying data: Yahoo Finance; company filings with the SEC.